PER 1.35% 7.5¢ percheron therapeutics limited

atl1103 successfully progresses towards phase , page-5

  1. 13,444 Posts.
    lightbulb Created with Sketch. 1
    Like the success, the potential partnering being entertained and this for later."The mitogenic and apoptotic parameters" for experimental cancer program.


    all fine and dandy here IMO
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.